August 29, 2014 5:44 AM ET

Pharmaceuticals

Company Overview of CureVac GmbH

Company Overview

CureVac GmbH, a biopharmaceutical company, develops therapeutic messenger RNA vaccines for cancer and prophylactic vaccines for infectious diseases. The company provides RNActive molecules as immunotherapeutics for the treatment of cancer and as prophylactic vaccines against infectious diseases. It also develops adjuvants based on non-coding RNAs (RNAdjuvant) for enhancing the immune response of other vaccines. CureVac GmbH has strategic partnership with Janssen Pharmaceuticals, Inc. and Sanofi Pasteur S.A. The company was founded in 2000 and is based in Tubingen, Germany.

Paul-Ehrlich-Straße 15

Tubingen,  72076

Germany

Founded in 2000

Phone:

49 70 71 9 20 53 100

Fax:

49 70 71 9 20 53 101

Key Executives for CureVac GmbH

Co-Founder and Chief Operating Officer
Chief Financial Officer
Chief Corporate Officer
Chief Medical Officer
Compensation as of Fiscal Year 2014.

CureVac GmbH Key Developments

CureVac Signs an Exclusive License Agreement with Sanofi Pasteur S.A.to Develop and Commercialize an mRNA-Based Prophylactic Vaccine

CureVac announced the execution of an exclusive license agreement with Sanofi Pasteur S.A. to develop and commercialize an mRNA-based vaccine against an undisclosed pathogen. Under the commercial license agreement, Sanofi Pasteur will fund all research, development, manufacturing and commercialization activities and will have exclusive worldwide marketing rights for the RNActive vaccine. CureVac will receive an undisclosed upfront payment from Sanofi Pasteur for the option exercise and an additional payment for extending the option term for the other pathogens. In addition, CureVac is eligible for additional milestone payments up to EUR 150.5 million for achieving several clinical, regulatory and commercial milestones, as well as royalty payments associated with products sales of RNActive vaccines.

CureVac GmbH Presents at BioEquity Europe 2014, May-21-2014 02:40 PM

CureVac GmbH Presents at BioEquity Europe 2014, May-21-2014 02:40 PM. Venue: Hilton Amsterdam Hotel, Amsterdam, Netherlands.

CureVac GmbH Presents at 8th Annual BIO Europe Spring 2014, Mar-11-2014 09:15 AM

CureVac GmbH Presents at 8th Annual BIO Europe Spring 2014, Mar-11-2014 09:15 AM. Venue: OVAL Lingotto, Turin, Italy.

Similar Private Companies By Industry

Company Name Region
Lichtwer Pharma AG Europe
Alsitan GmbH & Co. KG Europe
IDT Biologika GmbH Europe
InterMed Discovery GmbH Europe
Salutas Pharma GmbH Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CureVac GmbH, please visit www.curevac.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.